Skip to content

The Warwick Arthroplasty Trial

The Warwick Arthroplasty Trial: a randomised controlled trial of total hip arthroplasty versus resurfacing hip arthroplasty in the treatment of young patients with arthritis of the hip joint

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33354155
Enrollment
172
Registered
2007-09-17
Start date
2007-06-01
Completion date
Unknown
Last updated
2023-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip joint Musculoskeletal Diseases Coxarthrosis

Interventions

1. Patients in the Total Hip Arthroplasty group will have the head of their femur removed and replaced with a prosthetic component fixed inside the femoral shaft 2. Patients in the Hip Resurfacing Art

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Over the age of 18 2. Able to give informed consent 3. Eligible for hip resurfacing arthroplasty

Exclusion criteria

Exclusion criteria: Patients with a concomitant medical problem that will preclude operation.

Design outcomes

Secondary

MeasureTime frame
All secondary outcomes will be measured at pre-operation and 6, 12, 26 and 52 weeks post-operation: 1. Disability Rating Index 2. Physical activity level 3. Complication rate 4. Quality of life 5. Health economic evaluation

Primary

MeasureTime frame
1. Harris Hip Score, measured at pre-operation and 6, 12, 26 and 52 weeks post-operation 2. Oxford Hip Score, measured at pre-operation and 6, 12, 26 and 52 weeks post-operation

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 1, 2026